- https://git.cjcrace.io/maricela19r435
-
Subcutaneous abdominal fat decreased only 6.8% in the tesamorelin cohort, confirming VAT selectivity. Participants receiving 2mg daily tesamorelin showed mean VAT reduction of 15.2% versus 4.1% in the placebo group.
- Joined on
2026-04-03
No matching repositories found.